PxB Fund
OUP
◆ Investment Thesis
A dedicated venture capital fund focused on early-stage life science companies originating from University of Pennsylvania research, translating science into products like therapeutics, diagnostics, and AI-enabled drug discovery platforms.
◆ About OUP
The PxB Fund (Penn-BioNTech Innovative Therapeutics Seed Fund) is a $50 million venture capital fund launched by the University of Pennsylvania, BioNTech, and Osage University Partners (OUP) to invest in early-stage life science companies originating from Penn. It focuses on seed and Series A investments in novel therapeutics, diagnostics, research tools, and AI-enabled drug discovery platforms addressing serious medical conditions. Managed by OUP, the fund accelerates the translation of Penn biomedical research into patient-impacting products.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does PxB Fund invest in?
PxB Fund invests in Biotech, Diagnostics, Drug Discovery, Generative AI and Digital Health at the seed and series-a stages.
Which geographies does PxB Fund focus on?
PxB Fund focuses on United States, and is headquartered in US.
What is PxB Fund's typical check size?
PxB Fund typically writes checks of $0.5M to $5M.